| _version_ | 1866901308713205760 |
|---|---|
| author | Tripdatabase |
| author_facet | Tripdatabase |
| contents | Current evidence does not conclusively demonstrate that proactive treatment of Sjogren's syndrome reduces the risk of lymphoma or gland damage, though effective management may potentially lower overall complication risks. |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_19643849 |
| institution | Zenodo |
| language | |
| publishDate | 2026 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | Does proactive treatment of Sjogren's syndrome reduce the risk of lymphoma or gland damage? Tripdatabase Sjogren's syndrome lymphoma gland damage proactive treatment risk reduction Current evidence does not conclusively demonstrate that proactive treatment of Sjogren's syndrome reduces the risk of lymphoma or gland damage, though effective management may potentially lower overall complication risks. |
| title | Does proactive treatment of Sjogren's syndrome reduce the risk of lymphoma or gland damage? |
| topic | Sjogren's syndrome lymphoma gland damage proactive treatment risk reduction |
| url | https://doi.org/10.5281/zenodo.19643849 |